Percentage Of Shares Option Exercised

No definition available.

Name:	atnx_PercentageOfSharesOptionExercised
Namespace Prefix:	atnx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_SubsegmentsAxis=atnx_QuadPharmaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsegmentsAxis=atnx_PolymedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Contingent Consideration - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions				1 Months Ended
	May 01, 2016	Apr. 01, 2016	Mar. 31, 2016	Mar. 31, 2016
QuaDPharma
Number of Common stock issued				38,033
Common stock per share			$ 9.00	$ 9.00
Cash paid of remaining liability	$ 0.7
QuaDPharma \| Maximum
Exercised option to pay up to			50.00%	50.00%
Polymed
Number of Common stock issued			277,777
Common stock per share			$ 9.00	$ 9.00
Cash paid of remaining liability		$ 2.5
Polymed \| Maximum
Exercised option to pay up to			50.00%	50.00%